ORION PHARMA A/S: Financial statements 2016
CVR: 20601116
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 373,655,929 and a net result of DKK 56,727,015 compared with DKK 44,821,782 the year before. That is an increase of 36.9% compared with the year before. The profit margin was 15.2%. Equity in the 2016 report amounted to DKK 97,341,617. The solvency ratio was 59.9%. The company had 29 employees in the financial year.
- Revenue
- DKK 373,655,929
- Gross Profit
- DKK 101,018,653
- Profit/Loss
- DKK 56,727,015
- Equity
- DKK 97,341,617
- Total Assets
- DKK 162,424,998
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 373.7 mio. | 101 mio. | 56.7 mio. | 97.3 mio. | 29 |
| 2015 | 273 mio. | 85.3 mio. | 44.8 mio. | 66.6 mio. | 28 |
| 2014 | 166.9 mio. | 59.3 mio. | 24.7 mio. | 46.8 mio. | 31 |
| 2013 | 164.8 mio. | 64.9 mio. | 25.6 mio. | 39.1 mio. | 33 |
Official annual report
Find more companies like ORION PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ORION PHARMA A/S has published its annual report for 2015. Revenue came to DKK 272,966,662, and the net result was DKK 44,821,782.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.